109 related articles for article (PubMed ID: 19671951)
1. Timing of zero dose of OPV, first dose of hepatitis B and BCG vaccines.
Kuruvilla TA; Bridgitte A
Indian Pediatr; 2009 Nov; 46(11):1013-5. PubMed ID: 19671951
[TBL] [Abstract][Full Text] [Related]
2. Infant vaccination timing: Beyond traditional coverage metrics for maximizing impact of vaccine programs, an example from southern Nepal.
Hughes MM; Katz J; Englund JA; Khatry SK; Shrestha L; LeClerq SC; Steinhoff M; Tielsch JM
Vaccine; 2016 Feb; 34(7):933-41. PubMed ID: 26788880
[TBL] [Abstract][Full Text] [Related]
3. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
[TBL] [Abstract][Full Text] [Related]
4. Mother and child service coverage: reproductive and child health programme in Alwar district, Rajasthan state.
Gupta RS; Gupta A; Gupta HO; Venkatesh S; Lal S
J Commun Dis; 2006 Mar; 38(1):79-87. PubMed ID: 17370693
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
[TBL] [Abstract][Full Text] [Related]
6. Sequencing of vaccine doses.
Kumar S; John TJ
Indian Pediatr; 1999 Nov; 36(11):1167-8. PubMed ID: 10745344
[No Abstract] [Full Text] [Related]
7. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of house-to-house versus fixed-site oral poliovirus vaccine delivery strategies in a mass immunization campaign in Egypt.
Linkins RW; Mansour E; Wassif O; Hassan MH; Patriarca PA
Bull World Health Organ; 1995; 73(5):589-95. PubMed ID: 8846484
[TBL] [Abstract][Full Text] [Related]
9. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
10. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
de la Hoz F; Perez L; de Neira M; Hall AJ
Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting immunization coverage levels in a district of India.
Balraj V; Mukundan S; Samuel R; John TJ
Int J Epidemiol; 1993 Dec; 22(6):1146-53. PubMed ID: 8144298
[TBL] [Abstract][Full Text] [Related]
12. Vaccine coverage with hepatitis B and other vaccines in the Colombian Amazon: do health worker knowledge and perception influence coverage?
de la Hoz F; Perez L; Wheeler JG; de Neira M; Hall AJ
Trop Med Int Health; 2005 Apr; 10(4):322-9. PubMed ID: 15807795
[TBL] [Abstract][Full Text] [Related]
13. [Long-term efficacy of infant hepatitis B immunization program].
Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
[TBL] [Abstract][Full Text] [Related]
14. Recommended childhood immunization schedule--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(2):35-40. PubMed ID: 9011782
[TBL] [Abstract][Full Text] [Related]
15. Recommended childhood immunization schedule--United States, 1998.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Jan; 47(1):8-12. PubMed ID: 9450723
[TBL] [Abstract][Full Text] [Related]
16. Households that harbour zero-dose children after door-to-door national immunization campaigns.
Tshikuka JG; Gueim M; Diallo PM
Trop Doct; 2007 Oct; 37(4):216-7. PubMed ID: 17988481
[TBL] [Abstract][Full Text] [Related]
17. Improved immunization practices reduce childhood hepatitis B infection in Tonga.
Danielsson N; Fakakovikaetau T; Szegedi E
Vaccine; 2009 Jul; 27(33):4462-7. PubMed ID: 19508908
[TBL] [Abstract][Full Text] [Related]
18. The effect of concurrent use of hepatitis B and Bacille Calmette-Guérin vaccination on anti-hepatitis B response.
Artan R; Erol M; Velipasaoglu S; Yegin O
Saudi Med J; 2004 Dec; 25(12):1939-42. PubMed ID: 15711671
[TBL] [Abstract][Full Text] [Related]
19. Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.
Taffs RE; Enterline JC; Rusmil K; Muhilal ; Suwardi SS; Rustama D; Djatnika ; Cobra C; Semba RD; Cohen N; Asher DM
Bull World Health Organ; 1999; 77(6):484-91. PubMed ID: 10427933
[TBL] [Abstract][Full Text] [Related]
20. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination.
Williams IT; Goldstein ST; Tufa J; Tauillii S; Margolis HS; Mahoney FJ
Pediatr Infect Dis J; 2003 Feb; 22(2):157-63. PubMed ID: 12586980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
